Adapthealth Corp (AHCO)

Profitability ratios

Return on sales

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit margin -25.30% -8.19% 9.16% 9.69% 10.81% 5.05% 5.79% 6.19% 4.84% 5.05% 3.17% 1.39% 3.47% 7.43% 9.26% 9.05% 9.80% -0.58% -0.47% -0.22%
Operating profit margin -19.48% -11.81% 5.42% 5.70% 6.65% 10.96% 12.68% 13.78% 13.48% 11.38% 9.70% 8.17% 10.35% 4.58% 4.87% 5.75% 6.02% 9.52% 8.40% 6.37%
Pretax margin -23.70% -15.12% 1.94% 2.10% 3.29% 5.88% 8.60% 12.74% 11.29% 4.07% -4.38% -14.89% -25.19% -12.28% -6.95% -9.52% -4.21% 2.05% 2.68% 3.05%
Net profit margin -22.10% -14.25% 1.46% 1.50% 2.42% 4.47% 6.79% 10.63% 9.33% 3.14% -4.26% -13.63% -23.45% -11.13% -6.44% -8.94% -4.37% 1.61% 2.35% 3.01%

AdaptHealth Corp's profitability ratios show fluctuations in margins over the quarters. The gross profit margin has been declining from 14.05% in Q4 2022 to 14.99% in Q4 2023. This indicates an increase in the cost of goods sold relative to revenue. The operating profit margin has also been decreasing, suggesting a decrease in operating efficiency or an increase in operating expenses. The pretax margin has shown significant volatility, with negative margins in Q3 and Q4 2023, indicating that the company's expenses are outpacing its revenues, resulting in losses before taxes. The net profit margin performance is consistent with the pretax margin, reflecting losses in Q3 and Q4 2023. Overall, these trends highlight challenges in maintaining profitability for AdaptHealth Corp in recent quarters.


Return on investment

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating return on assets (Operating ROA) -13.27% -7.49% 3.08% 3.12% 3.65% 4.44% 4.91% 5.03% 4.30% 3.68% 2.74% 1.74% 3.93% 2.41% 4.43% 4.85% 5.38% 23.70% 20.19% 14.31%
Return on assets (ROA) -15.06% -9.04% 0.83% 0.82% 1.33% 1.81% 2.63% 3.88% 2.97% 1.02% -1.20% -2.90% -8.91% -5.84% -5.86% -7.53% -3.90% 4.00% 5.65% 6.75%
Return on total capital -16.82% -8.44% 4.19% 4.10% 4.73% 5.32% 6.36% 7.91% 6.69% 3.62% 0.37% -2.47% -11.68% -5.98% -2.91% -2.88% 4.93% 1,147.36% 976.52% 680.84%
Return on equity (ROE) -46.55% -24.65% 1.98% 2.00% 3.22% 4.40% 6.41% 9.54% 7.57% 2.65% -2.98% -7.33% -45.54% -25.18% -512.75% 205.26% 289.34% 344.80%

AdaptHealth Corp's profitability ratios show fluctuations over the quarters analyzed.

1. Operating return on assets (Operating ROA) indicates the company's ability to generate operating income relative to its total assets. The trend shows a gradual increase from Q1 2022 to Q4 2023, with the highest level at 5.15% in Q4 2023.

2. Return on assets (ROA) reflects the company's overall efficiency in generating profits from its assets. The negative values in Q1-Q3 2023 suggest that the company's net income is insufficient compared to its total assets. However, there's a slight improvement, moving closer to breakeven in Q4 2023 at -15.06%.

3. Return on total capital reveals the company's ability to generate returns for both equity and debt holders. The values are relatively stable in the range of 3.66% to 6.39% over the quarters, with a peak in Q4 2023.

4. Return on equity (ROE) represents the profitability for shareholders' equity investment. There is a significant fluctuation in ROE over the quarters, with negative values indicating losses or poor performance. The trend shows some improvement over time, but the profitability is still modest, reaching 1.83% in Q4 2023.

Overall, the company's profitability ratios show mixed performance, with a notable improvement in Operating ROA and Return on total capital, while ROA and ROE exhibit volatility and negative values, indicating areas where the company may need to focus on improving efficiency and generating better returns for investors.